Brief: Protara Therapeutics Q3 EPS USD -0.87
03/11/2023 12:00
Nov 03 (Reuters) - Protara Therapeutics Q3 income from operations USD -10.7 million. * Q3 net income USD -9.86 million * Q3 operating expenses USD 10.7 million
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses